Tuberculosis

CHA

Tag: Tuberculosis

World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen

Mumbai (India) - As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid. Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018...

Read more

COVID-19: Avoiding a ‘second tragedy’ for those with TB

As the world grapples with the coronavirus COVID-19 global pandemic, Doctors Without Borders/Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide. People with tuberculosis (TB) are among the groups that may be particularly affected. Special attention will be needed to safeguard the continuity...

Read more

Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug

As J&J release earnings, MSF protests price of lifesaving TB drug in front of New York Stock Exchange New York, 22 January 2020—Médecins Sans Frontières (MSF) protested in front of the New York Stock Exchange in New York today, demanding...

Read more

MSF and TB activists disrupt opening of TB conference to protest drug corporations keeping life-saving medicines from people

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. Hyderabad, 30 October – Doctors Without Borders/Médecins Sans Frontières (MSF) joined tuberculosis (TB) activists to disrupt...

Read more

Chhattisgarh: Treating tuberculosis in the jungle

Since 2006, MSF is working in Sukma district of Southern Chhattisgarh in India, place of a longstanding low-intensity conflict between Indian security forces and Left-Wing Extremist group. The MSF team works to provide primary health care services to the population...

Read more

Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug

GENEVA - Doctors Without Borders/Médecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who...

Read more

Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?

GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third...

Read more

Manipur: Providing patient-centered HIV, TB, and hepatitis care to patients

When Thongsei Lupho, 44, first started feeling unwell, he suspected he had contracted Tuberculosis. He visited MSF’s clinic in Moreh, on the Indo-Myanmar border, where he was diagnosed with HIV. Lupho had used drugs in the past to gain social...

Read more

World Tuberculosis Day: Treating the untreatable

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...

Read more

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....

Read more

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF   For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB).  Pooja,...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons